We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+9.44%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$5.39B
AUM Growth
+$133M
Cap. Flow
-$208M
Cap. Flow %
-3.86%
Top 10 Hldgs %
12.8%
Holding
367
New
31
Increased
69
Reduced
178
Closed
28

Top Buys

Rank Stock Value
1
U icon
Unity
U
+$46.5M
2
DOCU
DocuSign
DOCU
+$45.3M
3
HRB icon
H&R Block
HRB
+$19M
4
ELF icon
e.l.f. Beauty
ELF
+$18.3M
5
WMS icon
Advanced Drainage Systems
WMS
+$17.8M

Sector Composition

Rank Sector Weight
1 Technology 20.49%
2 Healthcare 17.06%
3 Financials 15.2%
4 Consumer Discretionary 13.23%
5 Industrials 12.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EBIX
226
DELISTED
Ebix Inc
EBIX
$10.9M 0.2%
339,193
-142,958
-30% -$5.51M
MNRO icon
227
Monro
MNRO
$365M
$10.7M 0.2%
162,419
-65,382
-29% -$4.09M
CYTK icon
228
Cytokinetics
CYTK
$10.6B
$10.4M 0.19%
446,554
-109,130
-20% -$2.33M
MRTX
229
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$10.3M 0.19%
+60,387
New +$12M
ARNA
230
DELISTED
Arena Pharmaceuticals Inc
ARNA
$10.2M 0.19%
146,901
-20,453
-12% -$1.57M
PBH icon
231
Prestige Consumer Healthcare
PBH
$2.54B
$10.1M 0.19%
228,275
-8,055
-3% -$338K
CUZ icon
232
Cousins Properties
CUZ
$4.83B
$9.96M 0.18%
281,647
-10,046
-3% -$342K
TBPH icon
233
Theravance Biopharma
TBPH
$878M
$9.88M 0.18%
484,206
-67,624
-12% -$1.29M
LPRO
234
DELISTED
Open Lending Corp
LPRO
$9.65M 0.18%
272,513
-37,529
-12% -$1.42M
NVCR icon
235
NovoCure
NVCR
$2.06B
$9.63M 0.18%
72,880
-2,917
-4% -$461K
TLND
236
DELISTED
Talend S.A. American Depositary Shares
TLND
$9.52M 0.18%
149,595
-21,861
-13% -$1.14M
SWX icon
237
Southwest Gas
SWX
$6.63B
$9.44M 0.18%
+137,373
New +$8.7M
CCXI
238
DELISTED
ChemoCentryx, Inc.
CCXI
$9.27M 0.17%
180,816
-25,179
-12% -$1.51M
TPTX
239
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$9.18M 0.17%
97,015
-13,570
-12% -$1.61M
DK icon
240
Delek US
DK
$3.92B
$8.9M 0.17%
408,555
-14,654
-3% -$320K
CERS icon
241
Cerus
CERS
$516M
$8.81M 0.16%
1,465,393
+122,456
+9% +$833K
GLDD
242
DELISTED
Great Lakes Dredge & Dock
GLDD
$8.68M 0.16%
+595,092
New +$8.68M
OPLN
243
Openlane
OPLN
$4.48B
$8.21M 0.15%
547,441
-76,486
-12% -$1.3M
BGS icon
244
B&G Foods
BGS
$277M
$8.05M 0.15%
259,109
-121,949
-32% -$3.84M
VRRM icon
245
Verra Mobility
VRRM
$726M
$8.02M 0.15%
592,500
-83,298
-12% -$1.15M
TRHC
246
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$7.89M 0.15%
171,402
-26,014
-13% -$1.24M
IONS icon
247
Ionis Pharmaceuticals
IONS
$9.21B
$7.75M 0.14%
172,348
-5,956
-3% -$332K
AOS icon
248
A.O. Smith
AOS
$8.65B
$7.68M 0.14%
113,538
-15,844
-12% -$963K
ANDE icon
249
Andersons Inc
ANDE
$2.18B
$7.56M 0.14%
276,089
+98,969
+56% +$2.62M
IOVA icon
250
Iovance Biotherapeutics
IOVA
$2.94B
$7.48M 0.14%
236,184
-33,045
-12% -$1.37M

Similar funds

Peregrine Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Peregrine Capital Management held 367 positions worth $5.39B, up 2.5% from $5.26B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Peregrine Capital Management withdrew a net $208M in Q1 2021, closing 28 positions and reducing 178 holdings. Its most notable exit was ENVESTNET, INC., an estimated $41M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Peregrine Capital Management opened a new position in Unity worth $37.9M.

  • Peregrine Capital Management's largest Q1 2021 buy was Unity: 377,615 shares worth $37.9M.
  • Peregrine Capital Management added most to DexCom in Q1 2021, an estimated $13.8M increase.
  • Peregrine Capital Management's biggest Q1 2021 reduction was MasTec, cutting an estimated $39.9M.
  • Peregrine Capital Management fully exited ENVESTNET, INC. in Q1 2021, selling an estimated $41M.
  • Peregrine Capital Management's ten largest holdings make up 13% of its $5.39B portfolio in Q1 2021.
  • Peregrine Capital Management opened 31 new positions and closed 28 in Q1 2021.
  • Peregrine Capital Management's portfolio value rose 2.5% quarter-over-quarter to $5.39B.

Based on Peregrine Capital Management's 13F filing for Q1 2021, filed 11 May 2021.